BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Norouzi M, Hardy P. Clinical applications of nanomedicines in lung cancer treatment. Acta Biomater 2021;121:134-42. [PMID: 33301981 DOI: 10.1016/j.actbio.2020.12.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Han R, Guan Y, Li M, Xu A, Wu D, Li P, Wang E, Sun P, Fei G, Zhou S, Wang R, Wu YS. Efficacy and Safety of Nanoadministration in the Treatment of Non-Small-Cell Lung Cancer Is Good to Some Extent: A Systematic Review and Meta-Analysis. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/9017198] [Reference Citation Analysis]
2 Li W, Feng SS, Wu H, Deng J, Zhou WY, Jia MX, Shi Y, Ma L, Zeng XX, Zuberi Z, Fu D, Liu X, Chen Z. Comprehensive Analysis of CDK1-Associated ceRNA Network Revealing the Key Pathways LINC00460/LINC00525-Hsa-Mir-338-FAM111/ZWINT as Prognostic Biomarkers in Lung Adenocarcinoma Combined with Experiments. Cells 2022;11:1220. [PMID: 35406786 DOI: 10.3390/cells11071220] [Reference Citation Analysis]
3 Kumar P, Yadav N, Chaudhary B, Jain V, Balaramnavar VM, Alharbi KS, Alenezi SK, Al-Malki WH, Ghoneim MM, Alshehri S, Imam SS, Gupta MM. Promises of phytochemical based nano drug delivery systems in the management of cancer. Chem Biol Interact 2021;351:109745. [PMID: 34774839 DOI: 10.1016/j.cbi.2021.109745] [Reference Citation Analysis]
4 Sheffey VV, Siew EB, Tanner EEL, Eniola-Adefeso O. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery. Adv Healthc Mater 2022;11:e2101536. [PMID: 35032406 DOI: 10.1002/adhm.202101536] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Zhu X, Liu Z, Li J, Li Z, Si F, Yang H, Kong J. Dual signal amplification based on polysaccharide-initiated ring-opening polymerization and click polymerization for exosomes detection. Talanta 2021;233:122531. [PMID: 34215034 DOI: 10.1016/j.talanta.2021.122531] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yao L, Zuo M, Zhang N, Bai T, Huang Q. The Efficacy of 18F-FDG PET/CT and Superparamagnetic Nanoferric Oxide MRI in the Diagnosis of Lung Cancer and the Value of 18F-FDG PET/CT in the Prediction of Lymph Node Metastasis. Comput Math Methods Med 2021;2021:2448782. [PMID: 34552658 DOI: 10.1155/2021/2448782] [Reference Citation Analysis]
7 Yang Q, Zhu L, Ye M, Zhang B, Zhan P, Li H, Zou W, Liu J. Tumor Suppressor 4.1N/EPB41L1 is Epigenetic Silenced by Promoter Methylation and MiR-454-3p in NSCLC. Front Genet 2022;13:805960. [DOI: 10.3389/fgene.2022.805960] [Reference Citation Analysis]
8 Ding Y, Tong Z, Jin L, Ye B, Zhou J, Sun Z, Yang H, Hong L, Huang F, Wang W, Mao Z. An NIR Discrete Metallacycle Constructed from Perylene Bisimide and Tetraphenylethylene Fluorophores for Imaging-Guided Cancer Radio-Chemotherapy. Adv Mater 2022;34:e2106388. [PMID: 34821416 DOI: 10.1002/adma.202106388] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
9 Imam SS, Alshehri S, Altamimi MA, Hussain A, Alyahya KH, Mahdi WA, Qamar W. Formulation and Evaluation of Luteolin-Loaded Nanovesicles: In Vitro Physicochemical Characterization and Viability Assessment. ACS Omega 2022;7:1048-56. [PMID: 35036768 DOI: 10.1021/acsomega.1c05628] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ezhilarasan D, Lakshmi T, Mallineni SK. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges. Nanomedicine. [DOI: 10.2217/nnm-2021-0364] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Sheikh A, Alhakamy NA, Md S, Kesharwani P. Recent Progress of RGD Modified Liposomes as Multistage Rocket Against Cancer. Front Pharmacol 2022;12:803304. [DOI: 10.3389/fphar.2021.803304] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Zhang Z, Ma L, Luo J. Chondroitin Sulfate-Modified Liposomes for Targeted Co-Delivery of Doxorubicin and Retinoic Acid to Suppress Breast Cancer Lung Metastasis. Pharmaceutics 2021;13:406. [PMID: 33808649 DOI: 10.3390/pharmaceutics13030406] [Reference Citation Analysis]
13 Garcia Diosa JA, Gonzalez Orive A, Weinberger C, Schwiderek S, Knust S, Tiemann M, Grundmeier G, Keller A, Camargo Amado RJ. TiO2 nanoparticle coatings on glass surfaces for the selective trapping of leukemia cells from peripheral blood. J Biomed Mater Res B Appl Biomater 2021. [PMID: 33982864 DOI: 10.1002/jbm.b.34862] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Lu F, Zhang H, Pan W, Li N, Tang B. Delivery nanoplatforms based on dynamic covalent chemistry. Chem Commun (Camb) 2021;57:7067-82. [PMID: 34195709 DOI: 10.1039/d1cc02246f] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Zhong T, Liu X, Li H, Zhang J. Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model. Drug Deliv 2021;28:2108-18. [PMID: 34607478 DOI: 10.1080/10717544.2021.1979129] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Liu C, Yao W, Zhou H, Chen H, Yu S, Qiao W. Series of High Magnetic Resonance-Guided Photoinduced Nanodelivery Systems for Precisely Improving the Efficiency of Cancer Therapy. ACS Appl Mater Interfaces 2022;14:20616-27. [PMID: 35471860 DOI: 10.1021/acsami.2c01256] [Reference Citation Analysis]
17 Kumar K, Chawla R. Nanocarriers-mediated therapeutics as a promising approach for treatment and diagnosis of lung cancer. Journal of Drug Delivery Science and Technology 2021;65:102677. [DOI: 10.1016/j.jddst.2021.102677] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]